Bartkova J, Lukas J, Strauss M, Bartek J: Cell cycle related variation and tissue restricted expression of human cyclin D1 protein. J Pathol 172:237-245, 1994 Google Scholar
Casey G, Smith R, McGillivray D, Peters G, Dickson C: Characterization and chromosome assignment of the human homolog of int-2, a potential proto-oncogene. Mol Cell Biol 6:502-510, 1986 Google Scholar
Peters G: Inappropriate expression of growth factor genes in tumors induced by mouse mammary tumor virus. Semin Virol 2:319-328, 1991 Google Scholar
Dickson C, Fantl V, Gillett C, Brookes S, Bartek J, Smith R, Fisher C, Barnes D, Peters G: Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer. Cancer (Letters) 90:43-50, 1995 Google Scholar
Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF: Studies of HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712, 1989 Google Scholar
Borg Å, Sigurdsson H, Clark GM, Fernö M, Fuqua SAW, Olsson H, Killander D, McGuire WL: Association of INT2/HST1 co-amplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Br J Cancer 63:136-142, 1991 Google Scholar
Schuuring E, Verhoeven E, van Tinteren H, Peterse JL, Nunnink B, Thunnissen FBJM, Devilee P, Cornelisse CJ, van der Vijver M, Mooi WJ, Michalides RJAM: Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res 52:5229-5234, 1992 Google Scholar
Fantl V, Richards MA, Smith R, Lammie GA, Johnstone G, Allen D, Gregory W, Peters G, Dickson C, Barnes DM: Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. Eur J Cancer 26:423-429, 1990 Google Scholar
Lammie GA, Fantl V, Smith R, Schuuring E, Brookes S, Michalides R, Dickson C, Arnold A, Peters G: D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6:439-444, 1991 Google Scholar
Schuuring E, Verhofen E, Mooi WJ, Michalides R: Identification and cloning of two over-expressed genes, U21B31/PRAD1 and EMS1, within the amplified 11q13 region in human carcinomas. Oncogene 7:355-361, 1992 Google Scholar
Gillett CE, Fantl V, Fisher C, Bartek J, Dickson C, Barnes D, Peters G: Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54:1812-1817, 1994 Google Scholar
Buckley MF, Sweeney KJE, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CKW, Musgrove EA, Sutherland RL: Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127-2133, 1993 Google Scholar
Fantl V, Smith R, Brookes S, Dickson C, Peters G: Chromosome 11q13 abnormalities in human breast cancer. Cancer Surveys 18:77-94, 1993 Google Scholar
Seshadri R, Lee CSL, Hui R, McCaul K, Horsfall DJ, Sutherland RL: Cyclin D1 amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis. Clin Cancer Res 2:1177-1184, 1996 Google Scholar
Barbareschi M, Pelosio P, Caffo O, Buttitta F, Pellegrini S, Barbazza R, Dalla Palma P, Bevilacqua G, Marchetti A: Cyclin D1 gene amplification and expression in breast carcinoma: relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21waf1 immunohistochcmical expression. Int J Cancer 74:171-174, 1997 Google Scholar
Hui R, Cornish AL, McLelland RA, Robertson JFR, Blamey RW, Musgrove EA, Nicholson RI, Sutherland RL: Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer. Clin Cancer Res 2:923-928, 1996 Google Scholar
Weinstat-Saslow D, Merino MJ, Manrow RE, Lawrence JA, Bluth RF, Wittenbel KD, Simpson JF, Page DL, Steeg PS: Overexpression of cyclin D1 mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Med 1:1257-1260, 1995 Google Scholar
Zhang S-Y, Caamano J, Cooper F, Guo X, Klein-Szanto AJP: Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol 102:695-698, 1994 Google Scholar
Nielsen NH, Emdin SO, Cajander J, Landberg G: Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene 14:295-304, 1997 Google Scholar
Simpson JF, Quan DE, O'Malley F, Odom-Maryon T, Clarke PE: Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast. Am J Pathol 151:161-168, 1997 Google Scholar
Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81:323-330, 1995 Google Scholar
Evans T, Rosenthal ET, Youngblom J, Distel X, Hunt T: Cyclin: a protein specified by material mRNA in sea urchin eggs that is destroyed at the end of each cell division. Cell 33:389-396, 1983 Google Scholar
Sherr CJ: Mammalian G1 cyclins. Cell 73:1059-1065, 1993 Google Scholar
Morgan DO: Principles of CDK regulation. Nature 374:131-134, 1995 Google Scholar
Pardee AB: G1 events and regulation of cell proliferation. Science 246:603-608, 1989 Google Scholar
Peters G: Stifled by inhibitions. Natures 371:204-205, 1994 Google Scholar
Biggs JR, Kraft AS: Inhibitors of cyclin-dependent kinase and cancer. J Mol Med 73:509-514, 1995 Google Scholar
Sherr CJ: Cancer cell cycles. Science 274:1672-1677, 1996 Google Scholar
LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E: New functional activities for the p21 family of CDK inhibitors. Genes Devel 11:847-862, 1997 Google Scholar
Zetterberg A, Larsson O, Wiman KG: What is the restriction point? Curr Opin Cell Biol 7:835-842, 1995 Google Scholar
Fredersdorf S, Burns J, Milne AM, Packham G, Fallis L, Gillett CE, Royds JA, Peston D, Hall PA, Hanby AM, Barnes DM, Shousha S, O'Hare MJ, Lu X: High level expression of p27kip1 and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27kip1 and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci USA 94:6380-6385, 1997 Google Scholar
Assoian RK, Zhu X: Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progression. Curr Opin Cell Biol 9:93-98, 1997 Google Scholar
Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE: Cyclin E-CDK2 is a regulator of p27kip1. Genes Devel 11:1464-1478, 1997 Google Scholar
Vlach J, Hennecke S, Amati B: Phosphorylation-dependent degradation of the cyclin dependent kinase inhibitor p27kip1. EMBO J 16:5334-5344, 1997 Google Scholar
Juan G, Gong J, Traganos F, Darzynkiewicz Z: Unscheduled expression of cyclins D1 and D3 in human tumour cell lines. Cell Prolif 29:259-266, 1996 Google Scholar
Sewing A, Burger C, Brusselbach S, Schalk C, Lucibello FC, Muller R: Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP. J Cell Sci 104:545-554, 1993 Google Scholar
Musgrove EA, Hamilton JA, Lee CSL, Sweeny KJE, Watts CKW, Sutherland RL: Growth factor, steroid and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol Cell Biol 13:3577-3587, 1993 Google Scholar
Pusch O, Soucek T, Wawra E, Hengstschlager-Ottnad E, Bernaschek G, Hengstschlager M: Specific transformation abolishes cyclin D1 fluctuation throughout the cell cycle. FEBS Lett 385:143-148, 1996 Google Scholar
Zhu X, Ohtsubo M, Böhmer RM, Roberts JM, Assoian RK: Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2 and phosphorylation of the retinoblastoma protein. J Cell Biol 133:391-403, 1996 Google Scholar
Atadja P, Wong H, Veillete C, Riabowol K: Over-expression of cyclin D1 blocks proliferation of normal diploid fibroblasts. Exp Cell Res 217:205-216, 1995 Google Scholar
Kyo-Ho Han E, Begemann M, Sgambato A, Soh J-W, Doki Y, Xing W-Q, Liu W, Weinstein IB: Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kip1, inhibits growth and enhances apoptosis. Cell Growth Differ 7:699-710, 1996 Google Scholar
Lovec H, Sewing A, Lucibello FC, Muller R, Moroy T: Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras linke between cell cycle and malignant transformation. Oncogene 9:323-326, 1994 Google Scholar
Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM: Cyclin D1 transgene impedes lymphocytic maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 13:2124-2130, 1994 Google Scholar
Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669-671, 1994 Google Scholar
Fantl V, Stamp G, Andrews A, Rosewell I, Dickson C: Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Devel 9:2364-2372, 1995 Google Scholar
Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ, Weinberg RA: Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621-630, 1995 Google Scholar
Bartkova J, Lukas J, Müller H, Lützhøft D, Strauss M, Bartek J: Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 57:353-361, 1994 Google Scholar
Lukas J, Pagano M, Staskova Z, Draetta G, Bartek J: Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 9:707-718, 1994 Google Scholar
Gillett C, Smith P, Gregory W, Richards M, Millis R, Peters G, Barnes D: Cyclin D1 and prognosis in human breast cancer. Int J Cancer 69:92-99, 1996 Google Scholar
Nishio M, Koshikawa T, Yatabe Y, Kuroishi T, Suyama M, Nagatake M, Sugiura T, Ariyoshi Y, Mitsudomi T, Takahashi T, Takahashi T: Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers. Clin Cancer Res 3:1051-1058, 1997 Google Scholar
van Diest P, Michalides RJAM, Jannink I, van der Valk P, Meijer CJLM, Baak JPA: Cyclin D1 expression in invasive breast cancer. Am J Pathol 150:705-711, 1997 Google Scholar
Müller H, Lukas J, Schneider A, Warthoe P, Bartek J, Eilers M, Strauss M: Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 91:2945-2949, 1994 Google Scholar
Bates S, Parry D, Bonetta L, Vousden K, Dickson C: Absence of cyclin D/cdk complexes in cells lacking in functional retinoblastoma protein. Oncogene 9:1633-1640. 1994 Google Scholar
Herwig S, Strauss M: The retinoblastoma protein: a master regulator of cell cycle, differentiation and apoptosis. Eur J Biochem 246:581-601, 1997 Google Scholar
Dublin EA, Patel NK, Gillett CE, Smith P, Peters G, Barnes DM: Retinoblastoma and p16 proteins in mammary carcinoma: their relationship to cyclin D1 and histopathological parameters. Int J Cancer (Pred. Oncol.) 79:71-75, 1998 Google Scholar
Pietiläinen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma VM, Syrjänen K: Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival. Eur J Cancer 31A:329-333, 1995 Google Scholar
Sutherland RL, Prall OWJ, Alle KM, Wilcken NRC, Hui R, Ball JR, Sarcevic B, Henshall SM, Musgrove EA, Watts CKW: Cyclin-dependent kinases as downstream targets of oestrogen action: potential prognostic indicators and therapeutic targets. Endocrine Related Cancer 4:357-370, 1997 Google Scholar
Neuman E, Ladha MH, Lin N, Upton TM, Miller SJ, DiRenzo J, Pestell RG, Hinds PW, Dowdy SF, Brown M, Ewen ME: Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol 17:5338-5347, 1997 Google Scholar
Wilcken NRC, Prall OWJ, Musgrove EA, Sutherland RL: Inducible overexpression of cyclin D1 in breast cancer cells reduces the growth-inhibitory effects of antiestrogens. Clin Cancer Res 3:849-854, 1997 Google Scholar
Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson J-Å, Kushner PJ, Scanlan TS: Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277:1508-1510, 1997 Google Scholar
Gillett C, Lee AHS, Barnes DM: Cycline D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia. J Pathol 184:396-400, 1998 Google Scholar
Steeg PS, Abrams JS: Cancer prognostics: past, present and p27. Nature Med 3:152-154, 1997 Google Scholar
Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Morava-Protzner I, Kapusta L, Franssen E, Pritchard KI, Slingerland JM: Decreased levels of the cell-cycle inhibitor p27kip1 protein: prognostic implications in primary breast cancer. Nature Med 3:227-230, 1997 Google Scholar
Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM: Expression of cell cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med 3:222-225, 1997 Google Scholar
Tan P, Cady B, Wanner M, Worland P, Cukor B, Magi-Galluzzi C, Lavin P, Draetta G, Pagano M, Loda M: The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res 57:1259-1263, 1997 Google Scholar
Zukerberg LR, Yang WI, Gadd M, Thor AD, Koerner FC, Schmidt EV, Arnold A: Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show over-expression of the cyclin D1 oncogene. Modern Pathol 8:560-567, 1995 Google Scholar
McIntosh GG, Anderson JJ, Milton I, Steward M, Parr AH, Thomas MD, Henry JA, Angus B, Lennard TWJ, Horne CHW: Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene 11:885-891, 1995 Google Scholar
Michalides R, Hageman P, van Tinteren H, Houben L, Wientjens E, Klompmaker R, Peterse J: A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 73:728-734, 1996 Google Scholar
Pelosio P, Barbareschi M, Bonoldi E, Marchetti A, Verderio P, Caffo O, Bevilacqua P, Boracchi P, Buttitta F, Barbazza R, Palma PD, Gasparini G: Clinical significance of cyclin D1 expression in patients with node-positive breast carcinoma treated with adjuvant therapy. Ann Oncol 7:695-705, 1996 Google Scholar